These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures. Carrillo-Ballesteros FJ; Palafox-Sánchez CA; Franco-Topete RA; Muñoz-Valle JF; Orozco-Barocio G; Martínez-Bonilla GE; Gómez-López CE; Marín-Rosales M; López-Villalobos EF; Luquin S; Castañeda-Chávez A; Oregon-Romero E Clin Exp Med; 2020 Nov; 20(4):615-626. PubMed ID: 32506205 [TBL] [Abstract][Full Text] [Related]
3. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281 [TBL] [Abstract][Full Text] [Related]
4. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351 [TBL] [Abstract][Full Text] [Related]
5. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling. Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170 [TBL] [Abstract][Full Text] [Related]
6. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277 [TBL] [Abstract][Full Text] [Related]
7. Implications of IFNγ SNP rs2069705 in primary Sjögren's syndrome: transcriptional activation and B cell infiltration. Chen X; Li M; Li H; Liu M; Su J; Ji Y Am J Physiol Cell Physiol; 2024 May; 326(5):C1494-C1504. PubMed ID: 38406824 [TBL] [Abstract][Full Text] [Related]
8. Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome. Abdulahad WH; Kroese FG; Vissink A; Bootsma H J Autoimmun; 2012 Aug; 39(1-2):103-11. PubMed ID: 22341852 [TBL] [Abstract][Full Text] [Related]
9. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175 [TBL] [Abstract][Full Text] [Related]
10. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome. Karnell JL; Mahmoud TI; Herbst R; Ettinger R Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms and New Strategies for Primary Sjögren's Syndrome. Mavragani CP Annu Rev Med; 2017 Jan; 68():331-343. PubMed ID: 28099084 [TBL] [Abstract][Full Text] [Related]
12. B-cell populations and sub-populations in Sjögren's syndrome. Hamza N; Bos NA; Kallenberg CG Presse Med; 2012 Sep; 41(9 Pt 2):e475-83. PubMed ID: 22841377 [TBL] [Abstract][Full Text] [Related]
13. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325 [TBL] [Abstract][Full Text] [Related]
14. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease. Peck AB; Nguyen CQ; Ambrus J Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965 [TBL] [Abstract][Full Text] [Related]
15. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome. Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367 [TBL] [Abstract][Full Text] [Related]
16. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment. Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831 [TBL] [Abstract][Full Text] [Related]
17. Achaete-scute complex homologue 2 accelerates the development of Sjögren's syndrome-like disease in the NOD/ShiLtJ mouse. Kim SM; Kwon JE; Park JS; Seo HB; Jung KA; Moon YM; Lee J; Kwok SK; Cho ML; Park SH Immunol Lett; 2017 Oct; 190():26-33. PubMed ID: 28728856 [TBL] [Abstract][Full Text] [Related]
18. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome. Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167 [TBL] [Abstract][Full Text] [Related]
20. Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjögren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Nguyen CQ; Sharma A; She JX; McIndoe RA; Peck AB Exp Eye Res; 2009 Mar; 88(3):398-409. PubMed ID: 19103199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]